Cargando…
Decreased Expression of CXCR4 Chemokine Receptor in Bone Marrow after Chemotherapy in Patients with Non-Hodgkin Lymphomas Is a Good Prognostic Factor
BACKGROUND: CXCR4 chemokine receptor is constitutively expressed on normal and malignant B lymphocytes derived from patients with B-cell lymphoproliferative disorders and has a significant role in cell migration to lymph nodes and bone marrow. Non-Hodgkin's lymphomas (NHL) constitute a heteroge...
Autores principales: | Mazur, Grzegorz, Butrym, Aleksandra, Kryczek, Ilona, Dlubek, Dorota, Jaskula, Emilia, Lange, Andrzej, Kuliczkowski, Kazimierz, Jelen, Michal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4032278/ https://www.ncbi.nlm.nih.gov/pubmed/24859274 http://dx.doi.org/10.1371/journal.pone.0098194 |
Ejemplares similares
-
Low expression of microRNA-204 (miR-204) is associated with poor clinical outcome of acute myeloid leukemia (AML) patients
por: Butrym, Aleksandra, et al.
Publicado: (2015) -
High CD74 expression correlates with ZAP70 expression in B cell chronic lymphocytic leukemia patients
por: Butrym, Aleksandra, et al.
Publicado: (2013) -
Genetic variation of the gene coding for microRNA-204 (miR-204) is a risk factor in acute myeloid leukaemia
por: Butrym, Aleksandra, et al.
Publicado: (2018) -
Expression of microRNA-181 determines response to treatment with azacitidine and predicts survival in elderly patients with acute myeloid leukaemia
por: Butrym, Aleksandra, et al.
Publicado: (2016) -
Clinical response to azacitidine therapy depends on microRNA-29c (miR-29c) expression in older acute myeloid leukemia (AML) patients
por: Butrym, Aleksandra, et al.
Publicado: (2016)